The Department of Audiology and Speech Pathology at the University of Tennessee Health Science Center and the Department of Hearing and Speech Sciences at Vanderbilt University have secured a $2,399,454 grant to fund a five-year project to address the need for diversity in highly trained professionals in speech-language pathology.
Ardelyx wins FDA approval for phosphate absorption inhibitor – Pharmaceutical Technology
Xphozah’s approval was based on data from three Phase III clinical trials. Image Credit: Maxx-Studio / Shutterstock. The US Food and Drug Administration (FDA) approved
October 18, 2023